Please assess the completion status of the following clinical trial:

Trial Title: Airway Responses to Montelukast and Desloratadine.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* baseline FEV1 \> or = 65% predicted~* positive methacholine challenge (i.e. methacholine PC20 \< or = 16mg/ml~* positive allergen challenge~Exclusion Criteria:~* negative skin prick test~* lung condition/disease other than asthma~* currently use montelukast and/or desloratadine

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).